Adeno-associated virus gene therapy with cholesterol 24- Hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer’s Disease.
Molecular Therapy, 2010 Jan;18(1):44-53. doi: 10.1038/mt.2009.175. Epub 2009 Aug 4, Hudry E et al
Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer’s disease early phenotypes.
Molecular Neurodegeneration, 2014 Dec 18;9:60. doi: 10.1186/1750-1326-9-60, Marquer C et al
Cholesterol-24-hydroxylase (CYP46a1) inhibition and accumulation of neuronal cholesterol in hippocampus leads to amyloid production, neurodegeneration and paves the way for Alzheimer’s disease
Brain 2015 Aug: 138 : 2383-98, Djelti F et al
Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology
Human Molecular Genetics, 2015 Nov : 24 : 5965-76, Burlot MA et al
Cyp46-A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s Disease
Brain 2016, Mar;139(Pt 3):953-70. doi: 10.1093/brain/awv384. Epub 2016 Jan 29, Boussicault L et al
Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis
Front. Mol. Neurosci., 11 July 2017 ; Ayciriex et al, 2017
CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington’s Disease
Brain ; Kacher et al, 2019